Axon Enterprise Inc (AAXN) Shares Bought by UBS Asset Management Americas Inc.

UBS Asset Management Americas Inc. lifted its holdings in shares of Axon Enterprise Inc (NASDAQ:AAXN) by 83.9% in the fourth quarter, Holdings Channel reports. The fund owned 27,577 shares of the industrial products company’s stock after acquiring an additional 12,579 shares during the period. UBS Asset Management Americas Inc.’s holdings in Axon Enterprise were worth $731,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of AAXN. Victory Capital Management Inc. increased its position in shares of Axon Enterprise by 58.0% during the third quarter. Victory Capital Management Inc. now owns 8,507 shares of the industrial products company’s stock valued at $193,000 after acquiring an additional 3,124 shares during the last quarter. Miles Capital Inc. purchased a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $214,000. Roundview Capital LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $248,000. Cipher Capital LP purchased a new stake in shares of Axon Enterprise during the third quarter valued at approximately $404,000. Finally, Municipal Employees Retirement System of Michigan increased its position in shares of Axon Enterprise by 58.7% during the third quarter. Municipal Employees Retirement System of Michigan now owns 19,780 shares of the industrial products company’s stock valued at $448,000 after acquiring an additional 7,320 shares during the last quarter. 95.87% of the stock is owned by institutional investors.

How to Become a New Pot Stock Millionaire

In other Axon Enterprise news, CRO Joshua Isner sold 9,301 shares of the firm’s stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $36.34, for a total value of $337,998.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Luke Larson sold 36,105 shares of the firm’s stock in a transaction on Friday, March 2nd. The stock was sold at an average price of $36.62, for a total value of $1,322,165.10. The disclosure for this sale can be found here. Company insiders own 3.90% of the company’s stock.

Shares of Axon Enterprise Inc (NASDAQ AAXN) opened at $37.90 on Monday. Axon Enterprise Inc has a 52-week low of $20.57 and a 52-week high of $40.49. The stock has a market capitalization of $2,010.00, a price-to-earnings ratio of 151.60, a price-to-earnings-growth ratio of 3.89 and a beta of 0.88.

Axon Enterprise (NASDAQ:AAXN) last released its earnings results on Tuesday, February 27th. The industrial products company reported $0.13 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.21. Axon Enterprise had a return on equity of 8.17% and a net margin of 1.59%. The business had revenue of $94.65 million during the quarter, compared to the consensus estimate of $87.88 million. analysts anticipate that Axon Enterprise Inc will post 0.39 EPS for the current fiscal year.

A number of brokerages recently commented on AAXN. Imperial Capital reaffirmed an “in-line” rating and set a $38.00 price target (up from $25.00) on shares of Axon Enterprise in a research report on Tuesday, March 20th. CL King downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Friday, March 16th. They noted that the move was a valuation call. BidaskClub downgraded Axon Enterprise from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, March 6th. Sidoti downgraded Axon Enterprise from a “buy” rating to a “neutral” rating and set a $40.00 price target for the company. in a research report on Monday, March 5th. They noted that the move was a valuation call. Finally, Zacks Investment Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating and set a $43.00 price target for the company in a research report on Friday, March 2nd. Five investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $38.00.

ILLEGAL ACTIVITY WARNING: “Axon Enterprise Inc (AAXN) Shares Bought by UBS Asset Management Americas Inc.” was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3302218/axon-enterprise-inc-aaxn-shares-bought-by-ubs-asset-management-americas-inc.html.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. The company operates through two segments, TASER Weapons, and Software and Sensors. It offers TASER X26P and TASER X2 smart weapons for law enforcement; consumer CEWs; and replacement cartridges and consumables, as well as performance power magazines.

Want to see what other hedge funds are holding AAXN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise Inc (NASDAQ:AAXN).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AAXN)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Palatin Technologies  Earns Buy Rating from Analysts at HC Wainwright
Palatin Technologies Earns Buy Rating from Analysts at HC Wainwright
Zacks Investment Research Lowers Konica Minolta  to Sell
Zacks Investment Research Lowers Konica Minolta to Sell
ORIENT O/SEAS INTL  Upgraded by Zacks Investment Research to “Buy”
ORIENT O/SEAS INTL Upgraded by Zacks Investment Research to “Buy”
Zacks: Brokerages Expect Allergan  Will Announce Quarterly Sales of $3.59 Billion
Zacks: Brokerages Expect Allergan Will Announce Quarterly Sales of $3.59 Billion
AstraZeneca  – Analysts’ Recent Ratings Changes
AstraZeneca – Analysts’ Recent Ratings Changes
VICTORIA OIL & GAS  Raised to “Buy” at Zacks Investment Research
VICTORIA OIL & GAS Raised to “Buy” at Zacks Investment Research


© 2006-2018 Ticker Report. Google+.